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Background: Several wireless ECG devices are commercially available for possible screening, monitoring
and diagnosis of rhythms. The field is rapidly expanding, and some devices have demonstrated
acceptable qualities. The objective was to evaluate the accuracy, usability and diagnostic capabilities of
smartphone ECG in both patients and healthy controls.
Methods: We used a commercially available smartphone ECG device, connected wirelessly to a tablet, to
record a 30-s lead I ECG in 144 subjectsd20 of whom repeated the test after vigorous exercise. The
subjects included 94 patients under standard calculated 12-lead ECG surveillance; transcripts were
obtained shortly after the smartphone ECG was acquired.
Results: No significant differences were found in the QRS, frequency and QT intervals between the two
modalities. Smartphone ECG recordings separated pathologic rhythms (atrial fibrillation (AF)/flutter,
atrioventricular block, regular supraventricular rhythm, and pacing) from sinus rhythms with a sensi-
tivity of 0.75 and a specificity of 0.97. The specific diagnosis of AF appeared in 11 patients and was
detected with a sensitivity of 1 and a specificity of 0.94. There was a marginal decrease in the inter-
pretability of the smartphone ECG after exercise. Inter- and intraobserver variability was low.
Conclusions: Smartphone ECG accurately measures most baseline intervals and has acceptable sensitivity
and specificity for pathological rhythms, especially for AF. Vigorous activity has a minor influence on the
readability of the PR interval. Elderly patients may face challenges in recording a smartphone ECG
correctly without assistance. According to our findings, the smartphone ECG would be applicable as a
screening device for pathological rhythms.
Copyright © 2019, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Different wireless, single-lead real-time electrocardiogram
(ECG) devices are commercially available for efficient screening,
monitoring and on-demand diagnosis. Some devices have
demonstrated acceptable detection efficiencies for intervals and
rhythms [1e3]. ECG Check is an FDA-approved [4] mobile heart
monitor manufactured by Cardiac Designs. The method allows easy
acquisition, and the recording can be forwarded to a professional
interpreter of choice. Many of these do-it-yourself monitors are
available, but the question stands as to whether they truly work orergen, Norway.
Rhythm Society.
ociety. Production and hosting bymerely provide a false feeling of security. In this article we hope to
shed some light on this matter. Wanting to evaluate the accuracy
and usability of smartphone ECG (spECG)1, we studied both healthy
controls and patients. In the comparison of the spECG to a standard
calculated 12-lead ECG (scECG)2, our hypothesis was that the de-
vice would prove to be of poor clinical value. In addition, by using a
questionnaire, we wanted to quantify the user-friendliness, acces-
sibility, technological confidence, and need for assistance. The
study was approved by the Regional Committee for Medical and
Health Research Ethics (REK Vest 2016/729).1 Abbreviation: Smartphone ECG (spECG).
2 Abbreviation: Standard Calculated ECG (scECG).
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Questionnaire. Bar graph displaying the self-reported results from the ques-
tionnaire in the different age groups.
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This study was a prospective, nonrandomized, and adjudicator-
blinded study. After obtaining informed consent, we collected a
final number of 164 spECGs from a total of 144 persons. The study
population consisted of 37% females, and the mean age was 58
years. The participants were divided into subgroups based on age
(<25 years, 25e50 years, 50e75 years, or>75 years), each including
at least 20 subjects.
2.1. Acquisition
The subjects included 94 patients with ongoing scECG cardiac
surveillance admitted to the Cardiac Ward at Haukeland University
Hospital, Bergen. The subjects were given basic instructions on how
to use the spECG device and send the result to an email address
created for the purpose. By putting two fingers on the ECG Check, it
registers a 30-s, one-lead ECG and stores it on a device (smart-
phone, tablet) via Bluetooth. The application's algorithm then
classifies the spECGs as either “Normal” or “Abnormal”, and it also
estimates the frequency using the RR interval. Neither the fre-
quency estimation nor the application's classification of spECG was
regarded in the interpretation. The participants performed the
recording as independently as possible, supervised by study in-
vestigators and with assistance if needed. Shortly after acquiring
the spECG, scECG reports were extracted for comparison. Following
the ECG-acquisition process, all of the subjects completed a ques-
tionnaire subjectively assessing the performance and usability of
the device on a scale from 1 to 4. The observers rated any need for
assistance as “Yes” or “No”.
In total 50 asymptomatic controls were included on the criterion
of “no previously known heart disease”. In the group of healthy
controls <25 years old, 20 subjects were asked to do two spECG
acquisitions-one before and one after vigorous exercise. This
approach was used to ascertain whether physical activity influ-
enced the readability of the spECG or not. The exercise was high-
intensity but nonstandardized in form, and the subjects were at
rest during the acquisition process.
2.2. Data
The collected data were anonymized and were analyzed
manually and independently by two observers to avoid bias. The
agreement between the two observers was tested by the intraclass
correlation coefficient (ICC). Four standard ECG intervals were
measured (frequency, PR, QRS, and QT). The QTc interval was
calculated using a digital calculator based on Bazett's formula [5].
The frequency was determined by measurement of 10 beats and
calculation of mean RR time. For scECG, Lead 1was used tomeasure
all intervals. Lead 2 was used for frequency only, due to longer
duration on the transcript. The waveforms were not amplified.
2.3. Process
The subjects were diagnosed by the observers for the purpose of
the study, and five pathological diagnoses were employed in
addition to sinus rhythm (atrial fibrillation (AF), atrial flutter,
atrioventricular block, regular supraventricular rhythm and cardiac
pacing). Some of the ECGs were uninterpretable to the reader;
these were categorized as such but were included in the analysis in
order to quantify readability.
Using a 2 2 contingency table, the sensitivity and specificity
for two independent situations were estimated. We defined an
abnormality seen in both modalities as a true positive, a true
negative was no abnormality detected in either modality, a falsepositive was an abnormality only seen in the spECG and a false
negative was an abnormality only found in the scECG. Supraven-
tricular extrasystoles and ventricular extrasystoles were dis-
regarded due to their intermittent nature and the fact that spECG
and scECG did not correspond perfectly with each other in the
temporal aspect under the current study design.
Themeasured intervals from the twomodalities were compared
in Stata/IC [6]. A box plot containing a 95% confidence interval
demonstrated the variance. To determine if there was a statistically
significant difference between the two, a paired T-test was applied.3. Results
As demonstrated in Fig. 1, the percentage of smartphone owners
decreases with increasing age. The need for assistance in handling
the technology, as rated by the observer, increases correspondingly.
The same pattern applies to how easy the participants perceived
the recording process to be, but a large number in the older groups
reported being comfortable using this device independently when
given proper training and instruction.3.1. Statistics
A total of 820 spECG-intervals were measured. Of these, 10%
were uninterpretable to the reader due to poor quality and noise,
inconsistent findings or low wave amplitude on the spECG. These
data mean that one or more uninterpretable intervals were found
in 27% of the spECGs. The cause of this phenomenon was primarily
the PR intervals, of which 22% could not be interpreted (Fig. 3,
example 2).
The spECGs recorded during exercise in the control group
demonstrated a decrease in interpretability of the PR interval: from
95% pre-exercise to 87.5% postexercise. All other intervals remained
fully interpretable to the reader. In total, 80% of all spECGs showed
either coarse variations or finer higher frequency disturbances.
These variations and disturbances often occurred due to hand
movements at the beginning of the acquisition, but most were still
readable.
Observer agreement was tested by conducting an ICC, and the
intraobserver value was estimated to be> 0.8, while the interob-
server value was >0.6. These values were interpreted as excellent
and good, respectively [7].
By comparing the data from the spECG and scECG in the patient
Fig. 2. a: spECG vs scECG. Box plot displaying the four intervals (PR, QRS, QT, QTc) as
measured by scECG and spECG (n¼ 94). ECG¼ Electrocardiogram, Sc¼Standard
Calculated, Sp¼ Smartphone. b: spECG vs scECG. Box plot displaying the frequencies as
measured by scECG and spECG (n¼ 94). BPM ¼ Beats per minute, ECG¼ Electrocar-
diogram, Sc¼Standard Calculated, Sp¼ Smartphone.
Table 1
Accuracy of intervals (n¼ 94).
Significant discrepancies Insignificant discrepancies
PR (p¼ 0,0005) Frequency (p¼ 0,342)
QTc (p¼ 0,0089) QRS (p¼ 0,153)
QT (p¼ 0,156)
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nificance level of 0.05, 2 of the 5 intervals (PR and QTc) demon-
strated statistically significant differences. These results are
summarized in Table 1. To visualize the variation, the data were
presented as box plots, as shown in Fig. 2a and b.
3.2. Sensitivities and specificities
When all of the aforementioned pathological diagnoses (AFTable 2
Contingency table.
Abnormality Total True pos. False neg. False pos.
Pathology 94 21 7 2
AF 94 11 0 5
Pacemaker 94 3 6 0
Neg.¼ negative, NPV ¼ Neg.predictive value, Pos.¼ positive, PPV ¼ Pos. predictive value(n¼ 11), atrial flutter (n¼ 2), atrioventricular block (n¼ 4), regular
supraventricular rhythm (n¼ 2) or cardiac pacing (n¼ 9)) were
defined as abnormalities, the device demonstrated a sensitivity of
75% and a specificity of 97%. Of the pathological diagnoses, 70%
were identified identically in both modalities. When only the
presence of AF was defined as an abnormality, the sensitivity was
100%, while the specificity was 94%. However, this study included
only 11 individuals with AF. The data are displayed in Table 2.
4. Discussion
Many cardiac arrhythmias may be hard to identify, partly due to
their intermittent naturedonly 47% of symptomatic arrhythmias
are discovered using conventional 24-h Holter monitoring [8].
Some of these arrhythmias become manifest only during or after
strenuous physical activity and are occasionally symptoms of
potentially life-threatening conditions [9].
4.1. Arrhythmias
Exercise-induced arrhythmias would be easier to diagnose in
cases when the patient is symptomatic. This diagnosis requires a
device that can be used right after intense activity. Analysis of
healthy controls before and directly after vigorous exercise showed
only a slight decrease in interpretability for the PR intervals
(95e87.5%). This result is consistent with our finding that the PR
interval is the most frequent among the 10% of noninterpretable
intervals. The subjects were able to handle the device with an
elevated heart rate and a high level of activation. Disturbances were
present in all of the pre-exercise spECGs and they persisted in the
postexercise spECGs. In general, a high degree of artifacts and dis-
turbances was found, but the results were interpretable. This result
indicates that activity does not dramatically affect the interpret-
ability of the spECG. We believe the results to be applicable to the
more physically active part of the population.
Approximately 2e3% [10,11] of the general population has un-
diagnosed cardiac arrhythmias, and the consequences can be dire
[12,13]. It is estimated that 14,500 Norwegians suffer from a stroke
each year [14] and that up to 25% of these strokes are caused by
undetected and untreated AF [15]. One of the main risk factors for
AF is age [16], and the elderly population could potentially benefit
greatly from ECG Check. This benefit is especially important in new
cases of AF or in patients cardioverted by DC shock or medication.
At 6 months, 57% of patients with only AF experienced at least one
relapse [17], a condition which may go untreated. AF is easier to
treat and results in fewer complications with early detection [18].
However, the data collected in this study show that the need for
help in performing the spECG increases with age. These subjects
also experienced a significantly lower degree of confidence towards
and often a lack of access to the required technology. As this group
is probably the largest, one must take into account that they may
face problems using the device and will be in need of more
extensive education and follow up. Even though many of these
subjects reported to be confident using the technology indepen-
dently, this limitation might pose the biggest disadvantage of the
ECG Check.True neg. Sens (%) Spec (%) NPV PPV
64 75 97 0,9 0,91
78 100 94 1 0,69
85 33 1
, Sens.¼ sensitivity, Spec¼ specificity.
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To properly address these groups, the modern-day doctor may
need a supplement to conventional diagnostic methods, namely, a
suitable screening tool that fulfills both clinical and functional de-
mands in regard to usability, accuracy and availability. Earlier
studies of similar devices have shown reasonable cost-effectiveness
in certain populations [19]. Several studies have found that a one
lead-device may be useful for measuring different intervals, and
some have even stated that it is capable of identifying specific ab-
normalities in the PR interval [1]. The prerequisite for this is that no
significant difference can be detected between a one lead-device
and the gold standard. Comparing the spECG with the scECG for
accuracy, the paired T-test showed that this criterion is only partly
fulfilled with the examined device. This test is robust and suitable,
and displayed significant differences in 2 of the 5 intervals. A
possible explanation for this may be the PR-intervals lowamplitude
which often is obscured by disturbances, and therefore unreadable.Fig. 3. Comparison of modalities. Examples from theAs for the QTc interval the significant discrepancy may be the effect
of two slightly inaccurate measurements combined (Frequency and
QT).
Fig. 3 displays some of these challenges by demonstrating both
differences and similarities between the two modalities for AF and
sinus rhythm.
One of the main questions concerning spECG is whether the
sensitivity and specificity are sufficient for practical use or not. The
sensitivity and specificity for the five specified cardiac rhythms
were evaluated together in order to identify the validity of ECG
Check as a screening tool. The presence of a pacing device and/or
atrioventricular blockwas also included and classified as pathology.
The reason for not evaluating potentially pathological QRS intervals
but instead the PR interval was due to the latter's significant
discrepancy between the two modalities.
Whenwe estimated the occurrence of pathological rhythms, we
found a sensitivity of 75% to be acceptable, while a specificity of 97%
was deemed as very good. The high value given to the specificity isdata collected at Haukeland University Hospital.
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study and the fact that all diagnoses were included. However, a
paired comparison of the specific patient diagnoses showed that
the two modalities agreed completely in 70% of test subjects. In
summary, it would seem that even though spECG has a moderate
sensitivity, most abnormal findings will presumably be patholog-
ical (positive predictive value 0.91).
To explore the diagnostic capacity of ECG Check further, we
chose to focus on AF. In this regard, the device demonstrated both a
very high sensitivity and specificity, which is consistent with the
results of recent studies [1e3]. The greatest obstacle was the arti-
facts affecting the interpretability of the PR interval, causing some
atrial flutters to be categorized as AF. It should be clarified that
these findings are not representative of the general population, as
only 11 test subjects presented AF. The data indicate a quality that
should be further assessed under more specific study designs.
4.3. Limitations
Our study has certain limitations. First, the included participants
were not randomized but were selected by convenience. This se-
lection method resulted in quite a heterogeneous age distribution
and a difference in size between the age groups. Second, the sample
size was relatively small and might therefore not be applicable to
the general population. Furthermore, the spECG presented a certain
amount of disturbances and uninterpretable waveforms, which
might have affected the interpretation of the results. The temporal
aspect of the spECG and standard calculated 12 lead ECG (scECG)
may cause errors assessing intermittent phenomena.
5. Conclusion
In conclusion, the ECG Check from Cardiac Designs demon-
strated acceptable sensitivities and specificities in detecting certain
pathological rhythms. The high detection rate of AF indicates that
this device is useful in this capacity, but further studies are needed
to confirm this finding. ECG Check is an easily accessible tool that
varies non-significantly from scECG when measuring the fre-
quency, QRS interval and QT interval. However, the PR and QTc
intervals showed significant variations. Vigorous exercise influ-
enced these intervals minimally; therefore, the device may be used
for activity-related symptoms. These qualities, combined with a
noncostly profile, make the spECG a valid screening device for the
general population. Elderly subjects do, to a larger extent, experi-
ence difficulties handling the device, and the need for help in
performing the spECG increases with age. Even though most of the
subjects belonging this group reported being confident using the
technology independently, this limitation might pose the biggest
disadvantage for ECG Check.
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